BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 1660150)

  • 1. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.
    Striessnig J; Murphy BJ; Catterall WA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.
    Nakayama H; Taki M; Striessnig J; Glossmann H; Catterall WA; Kanaoka Y
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9203-7. PubMed ID: 1656465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
    Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazipine, a novel photoaffinity probe for dihydropyridine receptors of calcium channels.
    Taki M; Nakayama H; Kanaoka Y
    FEBS Lett; 1991 Jun; 283(2):259-62. PubMed ID: 1646123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels.
    Peterson BZ; Tanada TN; Catterall WA
    J Biol Chem; 1996 Mar; 271(10):5293-6. PubMed ID: 8621376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor.
    Sharp AH; Imagawa T; Leung AT; Campbell KP
    J Biol Chem; 1987 Sep; 262(25):12309-15. PubMed ID: 3040737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit.
    Regulla S; Schneider T; Nastainczyk W; Meyer HE; Hofmann F
    EMBO J; 1991 Jan; 10(1):45-9. PubMed ID: 1846597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
    Striessnig J; Knaus HG; Glossmann H
    Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of benz(othi)azepine-binding regions within L-type calcium channel alpha1 subunits.
    Kraus R; Reichl B; Kimball SD; Grabner M; Murphy BJ; Catterall WA; Striessnig J
    J Biol Chem; 1996 Aug; 271(33):20113-8. PubMed ID: 8702733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity labeling of the purified skeletal muscle calcium antagonist receptor by a novel benzothiazepine, [3H]azidobutyryl diltiazem.
    Naito K; McKenna E; Schwartz A; Vaghy PL
    J Biol Chem; 1989 Dec; 264(35):21211-4. PubMed ID: 2556399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.
    Striessnig J; Glossmann H; Catterall WA
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9108-12. PubMed ID: 2174553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis.
    Peterson BZ; Johnson BD; Hockerman GH; Acheson M; Scheuer T; Catterall WA
    J Biol Chem; 1997 Jul; 272(30):18752-8. PubMed ID: 9228048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel?
    Krizanová O; Hudecová S; Orlický J; Zachar J
    Gen Physiol Biophys; 1989 Apr; 8(2):99-111. PubMed ID: 2550315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemical localization of the semotiadil binding region within the cardiac Ca2+ channel alpha1 subunit. Comparison with the skeletal muscle counterpart.
    Ii N; Kuniyasu A; Kawahara K; Shibano T; Schwartz A; Nakayama H
    FEBS Lett; 1998 Dec; 441(1):83-7. PubMed ID: 9877170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene and azumolene inhibit [3H]PN200-110 binding to porcine skeletal muscle dihydropyridine receptors.
    el-Hayek R; Parness J; Valdivia HH; Coronado R; Hogan K
    Biochem Biophys Res Commun; 1992 Sep; 187(2):894-900. PubMed ID: 1326958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of drug binding and action on L-type calcium channels.
    Hockerman GH; Peterson BZ; Johnson BD; Catterall WA
    Annu Rev Pharmacol Toxicol; 1997; 37():361-96. PubMed ID: 9131258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.